Results 151 to 160 of about 67,505 (283)

Risk of Relapse Upon Treatment Discontinuation in Rosacea: An Updated Systematic Review and Network Meta‐Analysis of Randomized Controlled Trials

open access: yesDermatologic Therapy, Volume 2026, Issue 1, 2026.
Background Rosacea treatments often lead to recurrence after discontinuation, highlighting the need for effective maintenance therapies. The long‐term efficacy of treatments in preventing relapse has not been systematically compared. Objectives To compare the risk of relapse upon treatment discontinuation after achieving clinical remission with both ...
Ilaria Trave   +8 more
wiley   +1 more source

Screening for an ivermectin slow-release formulation suitable for malaria vector control [PDF]

open access: yes, 2015
BACKGROUND: The prospect of eliminating malaria is challenged by emerging insecticide resistance and vectors with outdoor and/or crepuscular activity. Ivermectin can simultaneously tackle these issues by
Chaccour, Carlos   +6 more
core   +1 more source

A MODIFIED FILTER PAPER CULTURE TECHNIQUE FOR SCREENING OF STRONGYLOIDES STERCORALIS IVERMECTIN SENSITIVITY IN CLINICAL SPECIMENS [PDF]

open access: bronze, 2006
Pewpan M. Intapan   +5 more
openalex   +1 more source

Bovine Lungworm: Prevalence and Associated Risk Factors in Haramaya Town, Ethiopia

open access: yesJournal of Parasitology Research, Volume 2026, Issue 1, 2026.
Background Lungworm infection, caused by a nematode parasite, leads to bronchitis or pneumonia, high‐mortality rates in cattle, and significant economic losses. Objectives This study is aimed at assessing the prevalence of bovine lungworm and identify potential risk factors in Haramaya town, Ethiopia. Methods A cross‐sectional study design was employed
Tsedalu Yirsa   +2 more
wiley   +1 more source

“Rapid-Impact Interventions”: How a Policy of Integrated Control for Africa's Neglected Tropical Diseases Could Benefit the Poor [PDF]

open access: yes, 2005
Controlling seven tropical infections in Africa would cost just 40 cents per person per year, and would permanently benefit hundreds of millions of ...
Alan Fenwick   +14 more
core   +6 more sources

Prevalence of onchocerciasis, attitudes and practices and the treatment coverage after 15 years of mass drug administration with ivermectin in the Tombel Health District, Cameroon [PDF]

open access: gold, 2020
Sharon Mumah Nyagang   +7 more
openalex   +1 more source

Anthelmintic Effect of Chitosan‐Encapsulated Bromelain on Gastrointestinal Nematodes in Naturally Infected Goats in Kenya

open access: yesJournal of Parasitology Research, Volume 2026, Issue 1, 2026.
The emergence of anthelmintic resistance calls for the development of alternatives, including medicinal plant extracts. The present study was aimed at assessing the efficacy of chitosan‐encapsulated bromelain (EB) as an oral solution drug against GIN in goats.
Ahmota Romain Daïba   +5 more
wiley   +1 more source

Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.

open access: yesJournal of the American Medical Association (JAMA), 2022
S. Naggie   +27 more
semanticscholar   +1 more source

Determination of Ivermectin Residues in Bovine Liver Samples By ELISA and HPLC with Fluorescence Detection

open access: yesMedical Laboratory Journal, 2017
Background and Objectives: Ivermectin is an anti-parasitic medication frequently used in many food-producing animals. This study aimed to investigate the level of ivermectin residue in liver samples collected from slaughterhouses in Qazvin Province, Iran.
Davoodi Jabber   +2 more
doaj  

Treatment of cattle with ivermectin and its effect on dung degradation and larval abundance in a tropical savanna setting

open access: yesOne Health
When ingested as part of a blood meal, the antiparasitic drug ivermectin kills mosquitoes, making it a candidate for mass drug administration (MDA) in humans and livestock to reduce malaria transmission. When administered to livestock, most ivermectin is
Miriam Ruhinda   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy